Role of infectious diseases in human carcinogenesis

Environmental and Molecular Mutagenesis

Volumn 45, Issue 2-3, 2005, Pages 284-303

  Herrera, Luis A ^a   Benítez Bribiesca, Luis ^b   Mohar, Alejandro ^a   Ostrosky Wegman, Patricia ^c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Apoptosis; Bacteria; Helminths; Human cancer; Infection; Inflammation; Metabolism; Parasite; Proliferation; Virus

Indexed keywords

BACTERIAL INFECTION; BACTERIAL VIRULENCE; BRAIN CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CARCINOGENESIS; CHRONIC INFLAMMATION; COLON ADENOCARCINOMA; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENOMIC INSTABILITY; HELICOBACTER PYLORI; HELMINTHIASIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; IMMUNOSURVEILLANCE; KAPOSI SARCOMA; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOVIRINAE; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PARASITE VIRULENCE; RECTUM CANCER; REVIEW; SCHISTOSOMA HEMATOBIUM; SKIN CANCER; TONGUE CANCER; TRACHEA CANCER; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS VIRULENCE; WART VIRUS;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; COMMUNICABLE DISEASES; GENOMIC INSTABILITY; HELICOBACTER PYLORI; HELMINTHS; HUMANS; IMMUNOLOGIC SURVEILLANCE; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENIC VIRUSES;

HELICOBACTER PYLORI; HUMAN PAPILLOMAVIRUS; SCHISTOSOMA; VERMES;

EID: 17044374711     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20122     Document Type: Review

References (178)

1. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR. Noonan B, Guild BC, deJonge BL, et al. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-180.
2. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430-1434.
3. Anjarwalla KA. 1971. Carcinoma of the bladder in the coast province of Kenya. East Afr Med J 48:502-509.
4. Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Harkonen M, Hakama MK. 1996. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 144:142-149.
5. Arrand JR. 1998.Epstein-Bar virus. In:Arrand JR, Harper DR, editors. Vius and human cancer. Oxford:Bios Scientific Publishers. p 65-92.
6. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Backstrom A, et al. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305:519-522.
7. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
8. Benchimol S, Minden MD. 1998. Virus oncogens and Tumor Suppressor genes. In: Tannock IF, Hill RP, editors. The basic science of oncology. New York: McGraw-Hill. p 79-107.
9. Bertoni F, Cavalli F, Cotter FE, Zucca E. 2002. Genetic alterations underlying the pathogenesis of MALT lymphoma. Hematol J 3:10-13.
10. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93:1325-1330.
11. Bhamarapravati N, Virranuvatti V. 1966. Liver diseases in Thailand. An analysis of liver biopsies. Am J Gastroenterol 45:267-275.
12. Bishop J. 1985. Viral oncogenes. Cell 42:23-38.
13. 2-induced DNA single strand breaks are inhibited by antioxidative vitamins in V79 cells. Chem Biol Interact 86:199-211.
14. Blaser MJ, Parsonnet J. 1994. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94:4-8.
15. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115.
16. Bosch FX, Ribes J, Diaz M, Cleries R. 2004. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5-S16.
17. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3:1151-1157.
18. Boshoff C, Weiss R. 2002. AIDS-related malignancies. Nat Rev 2: 373-382.
19. Bunyaratvej S, Meenakanit V, Tantachamrun T, Srinawat P, Susilaworn P, Chongchitnan N. 1981. Nationwide survey of major liver diseases in Thailand analysis of 3 305 biopsies as to year-end 1978. J Med Assoc Thai 64:432-439.
20. Burcham PC. 1998. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis 13:287-305.
21. Butel JS. 2000. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426.
22. Byrne MF, Murphy JF, Corcoran PA, Atherton JC, Sheehan KM, Cox D, Murray FE, Fitzgerald DJ. 2003. Helicobacter pylori induces cyclooxygenase-1 and cydooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol 38:1023-1030.
23. Cai HF, Cai F, Fan ZP. 1991. Determination of the rate of micronucleus formation in lymphocytes in liver diseases and its clinical significance. Zhonghua Nei Ke Za Zhi 30:289-290, 318.
24. Carbone M, Klein G, Gruber J, Wong M. 2004. Modern criteria to establish human cancer etiology. Cancer Res 64:5518-5524.
25. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. 2001. MALT lymphomas. Hematology (Am Soc Hematol Educ Prog) 1:241-258.
26. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648-14653.
27. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
28. Chen MG. 1989. Progress and problems in schistosomiasis control in China. Trop Med Parasitol 40:174-176.
29. Clifford G, Smith J, Plummer M, Munoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63-73.
30. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. 1975. A model for gastric cancer epidemiology. Lancet 2:58-60.
31. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, et al. 2000. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 92:1881-1888.
32. Crabtree JE. 1996. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 215(Suppl):3-10.
33. Crabtree JE. 1998. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci 43(Suppl 9):46S-55S.
34. Crompton DW. 1999. How much human helminthiasis is there in the world? J Parasitol 85:397-403.
35. Cutler AF, Prasad VM. 1996. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 91:85-88.
36. Danesh J. 1999. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 13:851-856.
37. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. 2004. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380.
38. de The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, et al. 1978. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756-761.
39. de The G. 1995. Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect 103(Suppl 8):269-273.
40. Depil S, Roche C, Dussart P, Prin L. 2002. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 16:254-259.
41. Dixon MF. 1991. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 6:125-130.
42. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. 1992. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834-835.
43. Duensing S, Duensing A, Crum CP, Munger K. 2001. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 61:2356-2360.
44. Dunn BE, Cohen H, Blaser MJ. 1997. Helicobacter pylori. Clin Microbiol Rev 10:720-741.
45. Durst M, Gissmann L, Ikenberg H, zur Hausen H. 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812-3815.
46. El-Sheikh SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani EN. 2001. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. Br J Urol Int 88:921-927.
47. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. 1999. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94:2373-2379.
48. Everett SM, Singh R, Leuratti C, White KL, Neville P, Greenwood D, Marnett LJ, Schorah CJ, Forman D, Shuker D, et al. 2001. Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev 10:369-376.
49. Fattovich G, Stroffolini T, Zagni I, Donato F. 2004. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:535-550.
50. Feig DI, Reid TM, Loeb LA. 1994. Reactive oxygen species in tumorigenesis. Cancer Res 54(Suppl 7):1890S-1894S.
51. Flisser A, Gonzalez D, Plancarte A, Ostrosky P, Montero R, Stephano A, Correa D. 1990. Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis: II, immunological and cytogenetic studies. Parasitol Res 76:640-642.
52. Frenkel K. 1992. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 53:127-166.
53. Gallagher B, Wang Z, Schymura MJ, Khan A, Fordyce J. 2001. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154:544-556.
54. Gentile JM, Gentile GJ, Nannenga B, Johnson M, Blankespoor H, Montero R. 1998. Enhanced liver cell mutations in trematode-infected Big Blue transgenic mice. Mutat Res 400:355-360.
55. Gerbitz A, Mautner J, Geltinger C, Hortnagel K, Christoph B, Asenbauer H, Klobeck G, Polack A, Bornkamm GW. 1999. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene 18:1745-1753.
56. Grassmann R, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U. 1992. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol 66:4570-4575.
57. Green A, Uttaravichien T, Bhudhisawasdi V, Chartbanchachai W, Elkins DB, Marieng EO, Pairqjkul C, Dhiensiri T, Kanteekaew N, Haswell-Elkins MR. 1991. Cholangiocarcinoma in north east Thailand: a hospital-based study. Trop Geogr Med 43:193-198.
58. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
59. Griffin BE, Bjorck E, Bjursell G, Lindahl T. 1981. Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol 40:11-19.
60. Guo HH, Loeb LA. 2003. Tumbling down a different pathway to genetic instability. J Clin Invest 112:1793-1795.
61. Guzman P, Sotelo-Regil RC, Mohar A, Gonsebatt ME. 2003. Positive correlation between the frequency of micronucleated cells and dysplasia in Papanicolaou smears. Environ Mol Mutagen 41: 339-343.
62. Hamada K, Yokoro K. 1995. Blocking of DNA synthesis in vitro by a guanosine 2′,3′-cyclic phosphate: a possible mechanism of chromosome aberrations induced by U5 snRNA. Mutat Res 326:71-82.
63. Harinasuta C, Harinasuta T. 1984. Opisthorchis viverrini: life cycle, intermediate hosts, transmission to man and geographical distribution in Thailand. Arzneimittelforschung 34:1164-1167.
64. Harrison T. 1998.Viral hepatitis and primary liver cancer. In: Arrand JR, Harper DR, editors. Viruses and human cancer. Oxford: Bios Scientific Publisher. pp 17-38.
65. Herrera LA, Santiago P, Rojas G, Salazar PM, Tato P, Molinari JL, Schiffmann D, Ostrosky-Wegman P. 1994. Immune response impairment, genotoxicity and morphological transformation induced by Taenia solium metacestode. Mutat Res 305:223-228.
66. Herrera LA, Benita-Bordes A, Sotelo J, Chavez L, Olvera J, Rascon A, Lopez M, Ostrosky-Wegman P. 1999. Possible relationship between neurocysticercosis and hematological malignancies. Arch Med Res 30:154-158.
67. Herrera LA, Ramirez T, Rodriguez U, Corona T, Sotelo J, Lorenzo M, Ramos F, Verdorfer I, Gebhart E, Ostrosky-Wegman P. 2000. Possible association between Taenia solium cysticercosis and cancer: increased frequency of DNA damage in peripheral lymphocytes from neurocysticercosis patients. Trans R Soc Trop Med Hyg 94:61-65.
68. Herrera LA, Ostrosky-Wegman P. 2001. Do helminths play a role in carcinogenesis? Trends Parasitol 17:172-175.
69. Howson CP, Hiyama T, Wynder EL. 1986. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 8:1-27.
70. Huang JQ, Sridhar S, Chen Y, Hunt RH. 1998. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169-1179.
71. Hwang ES, Nottoli T, Dimaio D. 1995. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211:227-233.
72. Ilyinskikh EN, Lepyehin AV, Logvinov SV, Ilyinskikh NN. 1998. Estimation of the mutagenic potential of the trematode Opisthorchis felineus in experimentally infected guinea pigs. Parasitol Res 84:570-572.
73. Imreh S, Szekely L, Wiman KG, Klein G. 1997.Mechanisms of oncogene perturbetion. In: Peters G, Vousden KH, editors. Oncogenes and tumor suppressors. Oxford: Oxford University Press. p 3-32.
74. International Agency for Research on Cancer. 1994. Schistosomes, liver flukes and Helicobacter pylori. Lyon:International Agency for Research on Cancer
75. Ishii A, Matsuoka H, Aji T, Hayatsu H, Wataya Y, Arimoto S, Tokuda H. 1989. Evaluation of the mutagenicity and the tumor-promoting activity of parasite extracts: Schistosoma japonicum and Clonorchis sinensis. Mutat Res 224:229-233.
76. Jackson S, Harwood C, Thomas M, Banks L, Storey A. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14:3065-3073.
77. Jeang KT, Giam CZ, Majone F, Aboud M. 2004. Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 279:31991-31994.
78. Kaposi M. 1872. Idiopatisches Multiplespigmentsarcom der haut. Arch Dermatologie Syphillis 4:265-273.
79. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918-924.
80. Keen PFP. 1980. Bladder cancer in an endemic schistosomiasis area: geographical and sex distribution. S Afr J Sci 76:228-230.
81. Khanzode SS, Khanzode SD, Dakhale GN. 2003. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett 195:27-31.
82. Kitinya JN, Lauren PA, Eshleman LJ, Paljarvi L, Tanaka K. 1986. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 80:935-939.
83. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. 2004. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127(5 Suppl 1):S17-S26.
84. Konno K, Oku Y, Nonaka N, Kamiya M. 1999. Hyperplasia of gastric mucosa in donor rats orally infected with Taenia taeniaeformis eggs and in recipient rats surgically implanted with the larvae in the abdominal cavity. Parasitol Res 85:431-436.
85. Kuper H, Adami HO, Trichopoulos D. 2000. Infections as a major preventable cause of human cancer. J Intern Med 248:171-183.
86. Kuppers R, Klein U, Hansmann M, Rajewsky K. 1999. Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520-1529.
87. Kurathong S, Lerdverasirikul P, Wongpaitoon V, Pramoolsinsap C, Kanjanapitak A, Varavithya W, Phuapradit P, Bunyaratvej S, Upatham ES, Brockelman WY. 1985. Opisthorchis viverrini infection and cholangiocarcinoma: a prospective, case-controlled study. Gastroenterology 89:151-156.
88. Lax AJ, Thomas W. 2002. How bacteria could cause cancer: one step at a time. Trends Microbiol 10:293-299.
89. Lee HH, Shiow SJ, Chung HC, Huang CY, Lin CL, Hsu JD, Shyu LY, Wang CJ. 2000. Development of brain injury in mice by Angiostrongylus cantonensis infection is associated with the induction of transcription factor NF-kappaB, nuclear protooncogenes, and protein tyrosine phosphorylation. Exp Parasitol 95:202-208.
90. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Johnstone I, Parsonnet J. 2004. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 13:4-10.
91. Li SD, Kersulyte D, Lindley IJ, Neelam B, Berg DE, Crabtree JE. 1999. Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun 67:3893-3899.
92. Liang T. 2004. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127:S62-571.
93. Liebowitz D. 1994. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21:376-381.
94. Liu MT, Chen YR, Chen SC, Hu CY, Lin CS, Chang YT, Wang WB, Chen JY. 2004. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 23:2531-2539.
95. Lucas SB. 1982. Squamous cell carcinoma of the bladder and schistosomiasis. East Afr Med J 59:345-351.
96. Maddrey WC. 2001. Hepatitis B: an important public health issue. Clin Lab 47:51-55.
97. Makhyoun NA, el-Kashlan KM, al-Ghorab MM, Mokhles AS. 1971. Aetiological factors in bilharzial bladder cancer. J Trop Med Hyg 74:73-78.
98. Marshall B. 1989.History of the discovery of C. pylory. In: Blaser MJ, editor. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku-Shoiun. p 7-23.
99. Martin GS. 2001. The hunting of the Src. Nat Rev Mol Cell Biol 2:467-475.
100. Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA. 2004. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 554:305-318.
101. McDougall JK. 1994. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186:101-119.
102. McKerrow JH. 1989. Parasite proteases. Exp Parasitol 68:111-115.
103. Meisels A, Fortin R. 1976. Condylomatous lesions of the cervix and vagina: I, cytologic patterns. Acta Cytol 20:505-509.
104. Meyer F, Ramanujam KS, Gobert AP, James SP, Wilson KT. 2003. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Heticobacter pylori. J Immunol 171:3913-3917.
105. Mobley HL. 1997. Helicobacter pylori factors associated with disease development. Gastroenterology 113(Suppl 6):S21-S28.
106. Mohar A, Ley C, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J. 2002. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. Am J Gastroenterol 97:2530-2535.
107. Molinari JL, Tato P, Reynoso OA, Cazares JM. 1990. Depressive effect of a Taenia solium cysticercus factor on cultured human lymphocytes stimulated with phytohaemagglutinin. Ann Trop Med Parasitol 84:205-208.
108. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. 2002. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 963:13-20.
109. Montero R, Gentile GJ, Frederick L, McMannis J, Murphy T, Silva G, Blankespoor H, Gentile JM. 1999. Induced expression of CYP2A5 in inflamed trematode-infested mouse liver. Mutagenesis 14:217-220.
110. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
111. Moss DJ, Burrows SR, Castelino DJ, Kane RG, Pope JH, Rickinson AB, Alpers MP, Heywood PF. 1983. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Im J Cancer 31:727-732.
112. Mostafa MH, Sheweita SA, O'Connor PJ. 1999. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 12:97-111.
113. Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K. 2004. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78:11451-11460.
114. Murray CJ, Lopez AD. 1997. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269-1276.
115. Ng RK, Lau CY, Lee SM, Tsui SK, Fung KP, Waye MM. 2004. cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun 322:827-835.
116. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136.
117. Ohshima H, Bartsch H. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305:253-264.
118. Omer RE, Kuijsten A, Kadaru AM, Kok FJ, Idris MO, El Khidir IM, van't Veer P. 2004. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma. Nutr Cancer 48:15-21.
119. Pan H, Zhou F, Gao SJ. 2004. Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res 64:4064-4068.
120. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L'Abbe KA, Wild CP. 1991. Liver cancer in Thailand: I, a case-control study of cholangiocarcinoma. Int J Cancer 48: 323-328.
121. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131.
122. Parsonnet J. 1995. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 9(Suppl 2):45-51.
123. Parsonnet J. 1999.Introduction. In:Parsonnet J, editor. Microbes and malignancy. New York:Oxford University Press. p 3-15.
124. Pelicci PG, Knowles DM II, Magrath I, Dalla-Favera R. 1986. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984-2988.
125. Pettit SJ, Seymour K, O'Flaherty E, Kirby JA. 2000. Immune selection in neoplasia: towards a microevolutionary model of cancer development. Br J Cancer 82:1900-1906.
126. Phares K. 1996. An unusual host-parasite relationship: the growth hormone-like factor from plerocercoids of spirometrid tapeworms. Int J Parasitol 26:575-588.
127. Pisani P, Parkin DM, Munoz N, Ferlay J. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6:387-400.
128. Polzer M, Overstreet RM, Taraschewski H. 1994. Proteinase activity in the plerocercoid of Proteocephalus ambloplitis (Cestoda). Parasitology 109(Pt 2):209-213.
129. Radkov SA, Kellam P, Boshoff C. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121-1127.
130. Raju T. 2002. The Nobel chronicles: a handbook of Nobel Prizes in phisiology or medicine 1901-2000. Bloomington, IN: 1st Books Library, Inc.
131. Raziuddin S, Masihuzzaman M, Shetty S, Ibrahim A. 1993. Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder. J Clin Immunol 13:23-29.
132. Rosin MP, Saad el Din Zaki S, Ward AJ, Anwar WA. 1994. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 305:283-292.
133. Rothman S. 1962.Medical research in Africa. In:Ackerman LV, editor. Geographic pathology, Kaposi's sarcoma, and cutaneos physiology of pachyderms. Basel:Karger.
134. Rous P. 1911. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397-411.
135. Rubin H. 1955. Quantitative relations between causative virus and cell in the Rous no. I chicken sarcoma. Virology 1:445-473.
136. Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F, Diss TC, Pan L, Isaacson PG. 1996. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 87:1255-1260.
137. Schatten S, Granstein RD, Drebin JA, Greene MI. 1984. Suppressor T cells and the immune response to tumors. Crit Rev Immunol 4:335-379.
138. Schauer D. 1999. Bacterial infection and colon cancer. In:Julie P, editor. Microbes and malignancy. New York:Oxford University Press. p 425-442.
139. Schmausser B, Mueller SO, Eck M, Moller M, Muller-Hermelink H, Stopper H. 2000. Helicobacter pylori induces DNA damage in vitro. Cancer Lett 152:145-149.
140. Shacter E, Weitzman SA. 2002. Chronic inflammation and cancer. Oncology (Huntingt) 16:217-226, 229.
141. Sheweita SA, El-Shahat FG, Bazeed MA, Abu El-Maati MR, O'Connor PJ. 2004. Effects of Schistosoma haematobium infection on drug-metabolizing enzymes in human bladder cancer tissues. Cancer Lett 205:15-21.
142. Sichangi M, Langat D, Mwenda J. 2002. Endogenous retrovirus sequences expressed in male mammalian reproductive tissues: a review. East Afr Med J 79:38-41.
143. Soll AH. 1996. Consensus conference: medical treatment of peptic ulcer disease - practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 275:622-629.
144. Solnick JV, Young GM. 2002.Bacterial pathogenicity islands and infectious diseases. In:Kado MSC, editor. Horizontal gene transfer,2nd ed. San Diego:Academic Press. p 111-121.
145. Stein M, Rappuoli R, Covacci A. 2000. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 97:1263-1268.
146. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, et al. 2000. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119:7-14.
147. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. 2000. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 68:4802-4804.
148. Takamatsu M, Fujita T, Hotta H. 2001. Suppression of serum starvation-induced apoptosis by hepatitis C virus core protein. Kobe J Med Sci 47:97-112.
149. Talib H. 1970. The problem of carcinoma of bilharzial bladder in Iraq. Br J Urol 42:571-579.
150. Tannock IF,Hill RP, editors. 1998. The basic science of oncology. New York:McGraw-Hill.
151. Temin H, Rubin H. 1958. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6:669-688.
152. Thomas JE, Bassett MT, Sigola LB, Taylor P. 1990. Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe. Trans R Soc Trop Med Hyg 84:551-553.
153. Thorley-Lawson DA, Gross A. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328-1337.
154. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
155. Trosko JE, Ruch RJ. 1998. Cell-cell communication in carcinogenesis. Front Biosci 3:D208-D236.
156. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. 2001. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789.
157. van Pelt J, Severi T, Grabble T, Eetveldt A, Verslype C, Roskams T, Fevery J. 2004. Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells. Cancer Lett 209:197-205.
158. Varmus H, Quintrll N, Wyke J. 1981. Revertants of an ASV-transformed rat cell line have lost the complete provirus or sustained mutations on src. Virology 108:28-46.
159. Vatanasapt V, Tangvoraphonkchai V, Titapant V, Pipitgool V, Viriyapap D, Sriamporn S. 1990. A high incidence of liver cancer in Khon Kaen Province, Thailand. Southeast Asian J Trop Med Public Health 21:489-494.
160. von Knebel Doeberitz M. 2002. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38:2229-2242.
161. Waggoner SE. 2003. Cervical cancer. Lancet 361:2217-2225.
162. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, Ozasa K, Kawai K. 1997. Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan. Dig Dis Sci 42:1383-1387.
163. Weinreb M, Day PJ, Niggli F, Green EK, Nyong'o AO, Othieno-Abinya NA, Riyat MS, Raafat F, Mann JR. 1996. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 87:3828-3836.
164. Weiss RA. 1998.Introducing viruses and cancer. In:Arrand JR, Harper DR, editors. Virus and human cancer. Oxford:Bios Scientific Publishers. p 1-15.
165. Whitby D, Smith NA, Talbot SJ. 1998.Kaposi's sarcoma and human herpesvirus-8. In:Arrand JR, Harper DR, editors. Virus and human cancer. Oxford:Bios Scientific Publishers.
166. White AC Jr, Robinson P, Kuhn R. 1997. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 66:209-230.
167. Wong-Staal F, Gallo RC. 1985. Human T-lymphotropic retroviruses. Nature 317:395-403.
168. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577.
169. Yoshida M. 1987. Expression of the HTLV-1 genome and its association with a unique T-cell malignancy. Biochim Biophys Acta 907:145-161.
170. Yoshida M, Suzuki T, Fujisawa J, Hirai H. 1995. HTLV-1 oncoprotein tax and cellular transcription factors. Curr Top Microbiol Immunol 193:79-89.
171. Yu M, Yuan J. 2004. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127:S72-S78.
172. Zhang B, Spandau D, Roman A. 2002. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J Virol 76:220-231.
173. Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, et al. 1997. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 11:1619-1626.
174. zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW. 1974. Attempts to detect virus-secific DNA in human tumors: I, nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 13:650-656.
175. zur Hausen H. 1976. Condylomata acuminate and human genital cancer. Cancer Res 36:530.
176. zur Hausen H. 1977. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78: 1-30.
177. zur Hausen H. 1996. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1288:F55-F78.
178. zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350.